bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2014: O S A J J M A M F J
2013: D N O

 
  Other news for:
Brain
Parkinson Disease
 Resources from HONselect
Study Supports Durability of Parkinson's Treatment
Transplanted brain neurons appear to remain healthy for up to 14 years, research shows

By Robert Preidt

THURSDAY, June 5, 2014 (HealthDay News) -- Therapeutic, transplanted brain cells producing the brain chemical dopamine remain viable in Parkinson's disease patients for many years, a new study reveals.

The findings "suggest that transplanted dopamine neurons can remain healthy and functional for decades," study co-author Ole Isacson, of Harvard University and McLean Hospital in Boston, said in a news release from the journal Cell Reports. The study was published in the journal on June 5.

As explained by the study authors, the tremors and other symptoms experienced by Parkinson's disease patients are caused by the loss of dopamine-producing neurons (brain cells). Healthy dopamine-producing neurons can be transplanted into patients' brains, but there were questions about how long the transplanted cells would remain healthy.

This study included five Parkinson's patients who had received transplants of fetal tissue-derived dopamine-producing neurons four to 14 years ago. Their transplanted dopamine neurons appeared healthy and showed no signs of Parkinson's disease-associated deterioration.

The findings provide further support for stem cells as a source for transplant-ready dopamine neurons, the study authors said. Isacson noted that neuronal transplant has proven to be a durable treatment for many Parkinson's patients, with some improving for years without any need for standard medications.

However, he added that the therapy is still not common, with access so far limited to patients participating in certain clinical trials.

Isacson called the new finding "extremely encouraging," adding that the long life of the transplanted neurons bodes well "for advancing [the technique] as a restoration therapy for Parkinson's disease."

More information

There's more on the illness at the National Parkinson's Foundation.

SOURCE: Cell Reports, news release, June 5, 2014

Copyright © 2014 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=688351

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Neurons
Therapeutics
Brain
Cells
Dopamine
Transplants
Stem Cells
Tremor
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact